Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dengue vaccine design: issues and challenges

M J Cardosa1

  • 1Institute of Health and Community Medicine, Universiti Malaysia Sarawak, Malaysia.

British Medical Bulletin
|November 27, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enterovirus 71 encephalomyelitis and Japanese encephalitis can be distinguished by topographic distribution of inflammation and specific intraneuronal detection of viral antigen and RNA.

Neuropathology and applied neurobiology·2012
Same author

Novel multiplex oligonucleotide-conjugated bead suspension array for rapid identification of enterovirus 71 subgenogroups.

Journal of clinical microbiology·2010
Same author

High-titred neutralizing antibodies to human enterovirus 71 preferentially bind to the N-terminal portion of the capsid protein VP1.

Archives of virology·2007
Same author

Molecular phylogeny of modern coxsackievirus A16.

Archives of virology·2007
Same author

Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand.

Vaccine·2005
Same author

Mary Jane Cardosa--bringing local solutions to Sarawak, Malaysia.

The Lancet. Infectious diseases·2002

Dengue virus poses a global health threat, necessitating accelerated vaccine development. Understanding dengue pathogenesis and immune responses is crucial for creating safe and effective dengue vaccines.

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Dengue virus infection is a significant global health concern, with 2.5 billion people at risk.
  • The spread of four dengue virus serotypes has increased the incidence of dengue hemorrhagic fever (DHF).

Purpose of the Study:

  • To review lessons from classical pathogenesis studies in the context of current molecular virology knowledge.
  • To address challenges in designing safe dengue vaccines, including subunit and whole-virus approaches.
  • To highlight issues of antibody-dependent enhancement and immune potentiation of disease.

Main Methods:

  • Review of classical pathogenesis studies.
  • Integration of current knowledge on dengue virus molecular biology.
  • Analysis of challenges in vaccine design.

Related Experiment Videos

Main Results:

  • Classical studies offer valuable insights into dengue pathogenesis.
  • Antibody-dependent enhancement and immune potentiation are critical hurdles for vaccine development.
  • Understanding natural protection and recovery mechanisms is essential.

Conclusions:

  • Accelerated development of safe and effective dengue vaccines is imperative.
  • Further research into DHF pathogenesis and natural immunity is needed.
  • Addressing immunological challenges is key to successful dengue vaccine design.